Glass Geoffrey Michael's Form 4 filing
Avadel Pharmaceuticals PLC (AVDL) · filed Dec 10, 2024
- Accession no.
- 0001104659-24-127299
- Filed
- Dec 10, 2024
- Trade date
- Dec 10, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $199.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glass Geoffrey MichaelCIK 0001517718 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | Ordinary Shares | PPurchaseAcquired | +10,075 | $9.89 | +$99,641.75 | 69,075 | Indirect | |
| Dec 10, 2024 | Ordinary Shares | PPurchaseAcquired | +10,204 | $9.80 | +$99,999.2 | 75,904 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.